Subject Predicate Object
ySPIQnm5
a
Resource
Answer
Written answer
answer has question
imk65f10
answer has answering person
James O'Shaughnessy
answer text
<p>No such estimate has been made.</p><p>The following table shows the number of prescription items of leuprorelin acetate written in the United Kingdom and dispensed in the community in England, 2017. We do not hold data for Wales. Lupron is the brand name, used in the United States of America, for the chemical leuprorelin acetate. In the United Kingdom and Ireland, leuprorelin is marketed under the brand names Lutrate and Prostap.</p><table><tbody><tr><td><p>Chemical Name</p></td><td><p>Brand</p></td><td><p>Presentation</p></td><td><p>Items</p></td></tr><tr><td><p>Leuprorelin Acetate</p></td><td><p>Lutrate</p></td><td><p>Lutrate_1 month Depot Inj 3.75mg Vl+Dil</p></td><td><p>182</p></td></tr><tr><td><p>Leuprorelin Acetate</p></td><td><p>Lutrate</p></td><td><p>Lutrate_3 month Depot Inj 22.5mg Vl+Dil</p></td><td><p>611</p></td></tr><tr><td><p>Leuprorelin Acetate</p></td><td><p>Prostap</p></td><td><p>Prostap 3_DCS Inj 11.25mg Dil + Pfs</p></td><td><p>150,586</p></td></tr><tr><td><p>Leuprorelin Acetate</p></td><td><p>Prostap</p></td><td><p>Prostap 3_Depot Inj 11.25mg Vl + Dil Pfs</p></td><td><p>59</p></td></tr><tr><td><p>Leuprorelin Acetate</p></td><td><p>Prostap</p></td><td><p>Prostap SR_DCS Inj 3.75mg Dil + Pfs</p></td><td><p>41,771</p></td></tr><tr><td><p>Leuprorelin Acetate</p></td><td><p>Prostap</p></td><td><p>Prostap SR_Inj 3.75mg Vl + Dil Pfs</p></td><td><p>38</p></td></tr><tr><td><p>Leuprorelin Acetate</p></td><td><p>Total</p></td><td><p>Total</p></td><td><p>193,247</p></td></tr></tbody></table><p><em>Source</em>: Prescription Cost Analysis</p><p> </p>
answer given date
answer has answering body
Department of Health and Social Care
written answer has answering body
Department of Health and Social Care
Department of Health and Social Care
answering body has written answer
ySPIQnm5
answering body has answer
ySPIQnm5
imk65f10
question has answer
ySPIQnm5
James O'Shaughnessy
answering person has answer
ySPIQnm5